Italian vendor Esaote released its AU5 Harmonic ultrasound scanner at the Congress of the World Federation for Ultrasound Medicine and Biology in Buenos Aires, Argentina, earlier this month. In its standard configuration, the multidisciplinary scanner
Italian vendor Esaote released its AU5 Harmonic ultrasound scanner at the Congress of the World Federation for Ultrasound Medicine and Biology in Buenos Aires, Argentina, earlier this month. In its standard configuration, the multidisciplinary scanner allows users to optimize ultrasound studies via the use of a contrast agent, according to the Genoa-based company.
AU5 includes both color and power Doppler functions and can accommodate specialized probes, such as high-frequency probes up to 20 MHz, for superficial imaging as well as transducers targeted to intraoperative and surgical applications. It also offers networking capabilities that allow the user to send images and patient data through both a local area network and the Internet, according to Esaote.
The scanner appears to be the enhanced version of Esaote's AU4 system that the vendor has been working on with Bracco (SCAN 7/17/96). According to Esaote, the scanner's dedicated hardware and software that can utilize the second-harmonic imaging method are the first results of an ultrasound contrast research program established by Esaote in cooperation with Bracco.
AU5 is available for sale in international markets except for the U.S., where Esaote expects to be able to sell the scanner next year. The scanner is CE marked, according to Esaote.
Shaping the Future of Radiology in 2025: Trends, Threats, and Opportunities
January 10th 2025How do we respond to challenges with staff recruitment, cybersecurity, and looming hospital takeovers in radiology? This author assesses key trends in radiology and offers key insights to stay competitive in the field.
Can MRI Have an Impact with Fertility-Sparing Treatments for Endometrial and Cervical Cancers?
January 9th 2025In a literature review that includes insights from recently issued guidelines from multiple European medical societies, researchers discuss the role of magnetic resonance imaging (MRI) in facilitating appropriate patient selection for fertility-sparing treatments to address early-stage endometrial and cervical cancer.
Surveillance Breast MRI Associated with Lower Risks of Advanced Second Breast Cancers
January 8th 2025After propensity score matching in a study of over 3,000 women with a personal history of breast cancer, researchers found that surveillance breast MRI facilitated a 59 percent lower risk in advanced presentations of second breast cancers.